REPLIGEN CORP - 8-K Filing
Repligen agreed to acquire BioLife Solutions in a $1.8B deal combining cash and stock (Items: 1.01 Entry into a Material Definitive Agreement, 2.02 Results of Operations and Financial Condition, 7.01 Regulation FD Disclosure, 8.01 Other Events Repligen’s management also delivered an Employee Frequently Asked Questions memorandum on July 22, 2026)
Tickers: $RGEN